Turner Syndrome Market
Turner Syndrome Market Forecasts to 2030 - Global Analysis By Type (Mosaic Turner Syndrome and Classical Turner Syndrome), Drug Type (Oxandrolone, Oxandrin, Norditropin, Somatropin, Genotropin, Humatrope, Zomacton and Nutropin), Therapy Type, Diagnosis, Route Of Administration, End User and By Geography
According to Stratistics MRC, the Global Turner Syndrome Market is accounted for $4.23 billion in 2023 and is expected to reach $7.29 billion by 2030 growing at a CAGR of 8.1% during the forecast period. Turner syndrome is a chromosomal condition that affects females and results from a missing or incomplete X chromosome. Typically, females have two X chromosomes (XX), but individuals with Turner syndrome have either a missing X chromosome (X0) or abnormalities in one of the X chromosomes. Girls with turner syndrome often have specific physical characteristics including short stature, a webbed neck (extra folds of skin), a broad chest, low-set ears, and a high-arched palate.
According to the National Library of Medicine in 2017, about 1 in 2,500 new-born girls, worldwide, were affected with the Turner Syndrome.
Market Dynamics:
Driver:
Rising patient advocacy and awareness
Patient advocacy plays a crucial role in advocating for improved access to healthcare services and treatments. It often extends to policy initiatives aimed at improving the overall landscape for individuals with rare diseases like turner syndrome. Increased awareness often leads to early detection of Turner syndrome. It plays a crucial role in raising awareness, supporting research, and advocating for better treatment options. These groups facilitates collaboration between researchers, clinicians, and pharmaceutical companies.
Restraint:
Limited patient population
Turner Syndrome is a rare disorder which occurs in mostly one out of 2000 girls. So, there is less availability of natural history data, which is crucial for understanding the progression of the disease. Limited patient numbers makes it challenging to gather sufficient real-world evidence, potentially hindering the understanding of the long-term impact of therapies. Also, establishing the value of a therapy and securing reimbursement can be more complex. This aspect raises the complexities and hampers the market growth.
Opportunity:
Unmet medical needs
Turner Syndrome is a rare disorder and it presents several unmet medical needs that need effective and targeted therapies. Addressing these unmet medical needs requires collaboration between healthcare professionals, researchers, and pharmaceutical companies. The development of targeted therapies could significantly improve the management of Turner Syndrome, potentially leading to more effective and personalized treatment options. Pharmaceutical companies may see this as an opportunity to develop innovative treatments which in turn accelerates the market expansion.
Threat:
High development costs
The development of therapies for rare conditions such as turner syndrome often faces unique challenges, leading to high development costs. The limited number of potential patients makes it economically challenging for pharmaceutical companies to invest in the development of drugs or therapies for turner syndrome. Also, understanding the underlying genetic mechanisms, conducting preclinical studies, and navigating the regulatory processes for rare diseases require specialized expertise and resources. The combination of these factors can hamper the growth of the market.
Covid-19 Impact
Global healthcare services have been severely impacted by the COVID-19 epidemic. Due to the pandemic, resources were redirected, which caused delays in the treatment of non-urgent medical disorders, such as Turner syndrome. Patients have faced challenges in accessing regular check-ups, treatments, and support services. Additionally, the supply chain for the pharmaceutical sector experienced interruptions that impacted the availability of drugs and other healthcare supplies related to Turner syndrome. The market has further recovered to its pre-pandemic level.
The genotropin segment is expected to be the largest during the forecast period
The genotropin segment is estimated to have a lucrative growth. Genotropin is often used as part of a comprehensive treatment approach that includes hormone replacement therapy and other interventions to address various aspects of turner syndrome. It contributes to an improved quality of life for individuals with turner syndrome. It exhibits numerous benefits such as improved body composition, bone health, cardiovascular health, improvement of short stature and overall body growth.
The prenatal testing segment is expected to have the highest CAGR during the forecast period
The prenatal testing segment is anticipated to witness the highest CAGR growth during the forecast period. Prenatal testing plays a crucial role in the early diagnosis of turner syndrome. This early diagnosis can lead to timely interventions and appropriate management strategies, potentially improving outcomes for the affected individual. Knowing about the disorder during pregnancy allows parents to emotionally prepare for the challenges associated with the condition. As technology and genetic testing methods continue to advance, the accuracy and accessibility of prenatal testing for turner syndrome are likely to improve, further enhancing its role in patient care and family planning.
Region with largest share:
Asia Pacific is projected to hold the largest market share during the forecast period owing to the increasing awareness for women health, rising healthcare expenditures and growing healthcare sector. The Indian healthcare sector was one of the fastest growing industries. The developing countries like the India and China are investing heavily on healthcare infrastructure, professional doctors and R&D activities. Therefore, the increasing expenditure coupled with rising regularity of genetic disorders in females leads to the growth of the turner syndrome market in this region.
Region with highest CAGR:
Europe is projected to have the highest CAGR over the forecast period. Europe is home to several key players such as Novartis, Ipsen and Sanofi Genzym. These companies invest hugely on research activities related to rare genetic diseases. They often bring out latest innovations and solutions. Further, rise in technological innovations for rare disorders, huge patient population, increasing awareness regarding down syndromes and growing biotechnology sector are boosting the region’s market growth.
Key players in the market
Some of the key players profiled in the Turner Syndrome Market include Smiths Group, Pfizer Inc., Rocket Medical PLC, Medtronic, Novo Nordisk, Sanofi, Cooper Pharma, Eli Lilly and Company, Genentech, Lupin Pharmaceuticals Inc, Sandoz International GmbH, AbbVie Inc., Codexis, Merck & Co., American Gene Technologies, Johnson & Johnson Services Inc, F. Hoffmann-La Roche Limited, Ultragenyx Pharmaceutical, Abbott Laboratories and BioMarin.
Key Developments:
In October 2023, Novo Nordisk, a subsidiary of Novo Holdings AS, unveils Somapacitan (Sogroya) is a human growth hormone analog. It is formulated as solution for subcutaneous route of administration. Sogroya is indicated for the replacement of endogenous growth hormone (GH) in adults with growth hormone deficiency (GHD).
In March 2023, Sanofi and Provention Bio Inc, have entered into an agreement under which Sanofi has agreed to acquire Provention Bio, Inc. The acquisition is a strategic fit for Sanofi at the intersection of the company’s growth in immune-mediated diseases and disease-modifying therapies in areas of high unmet need, and its expertise in diabetes.
Types Covered:
• Mosaic Turner Syndrome
• Classical Turner Syndrome
Drug Types Covered:
• Oxandrolone
• Oxandrin
• Norditropin
• Somatropin
• Genotropin
• Humatrope
• Zomacton
• Nutropin
Therapy Types Covered:
• Progesterone Replacement Therapy
• Oestrogen Replacement Therapy
• Growth Hormone Therapy
• Psychological Therapy
• Other Therapy Types
Diagnosis Covered:
• Physical Examination
• Karyotyping
• Prenatal Testing
• Other Diagnosis
Route Of Administrations Covered:
• Oral
• Sub-cutaneous
• Intravenous
• Intramuscular
• Other Route Of Administrations
End Users Covered:
• Research Organizations
• Hospitals & Clinics
• Academic Institutes
• Other End Users
Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Table of Contents
1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 End User Analysis
3.7 Emerging Markets
3.8 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Turner Syndrome Market, By Type
5.1 Introduction
5.2 Mosaic Turner Syndrome
5.3 Classical Turner Syndrome
6 Global Turner Syndrome Market, By Drug Type
6.1 Introduction
6.2 Oxandrolone
6.3 Oxandrin
6.4 Norditropin
6.5 Somatropin
6.6 Genotropin
6.7 Humatrope
6.8 Zomacton
6.9 Nutropin
7 Global Turner Syndrome Market, By Therapy Type
7.1 Introduction
7.2 Progesterone Replacement Therapy
7.3 Oestrogen Replacement Therapy
7.4 Growth Hormone Therapy
7.5 Psychological Therapy
7.6 Other Therapy Types
8 Global Turner Syndrome Market, By Diagnosis
8.1 Introduction
8.2 Physical Examination
8.3 Karyotyping
8.4 Prenatal Testing
8.4.1 Amniocentesis
8.4.2 Ultrasound Test
8.4.3 Chorionic Villus Sampling
8.5 Other Diagnosis
9 Global Turner Syndrome Market, By Route Of Administration
9.1 Introduction
9.2 Oral
9.3 Sub-cutaneous
9.4 Intravenous
9.5 Intramuscular
9.6 Other Route Of Administrations
10 Global Turner Syndrome Market, By End User
10.1 Introduction
10.2 Research Organizations
10.3 Hospitals & Clinics
10.4 Academic Institutes
10.5 Other End Users
11 Global Turner Syndrome Market, By Geography
11.1 Introduction
11.2 North America
11.2.1 US
11.2.2 Canada
11.2.3 Mexico
11.3 Europe
11.3.1 Germany
11.3.2 UK
11.3.3 Italy
11.3.4 France
11.3.5 Spain
11.3.6 Rest of Europe
11.4 Asia Pacific
11.4.1 Japan
11.4.2 China
11.4.3 India
11.4.4 Australia
11.4.5 New Zealand
11.4.6 South Korea
11.4.7 Rest of Asia Pacific
11.5 South America
11.5.1 Argentina
11.5.2 Brazil
11.5.3 Chile
11.5.4 Rest of South America
11.6 Middle East & Africa
11.6.1 Saudi Arabia
11.6.2 UAE
11.6.3 Qatar
11.6.4 South Africa
11.6.5 Rest of Middle East & Africa
12 Key Developments
12.1 Agreements, Partnerships, Collaborations and Joint Ventures
12.2 Acquisitions & Mergers
12.3 New Product Launch
12.4 Expansions
12.5 Other Key Strategies
13 Company Profiling
13.1 Smiths Group
13.2 Pfizer Inc.
13.3 Rocket Medical PLC
13.4 Medtronic
13.5 Novo Nordisk
13.6 Sanofi
13.7 Cooper Pharma
13.8 Eli Lilly and Company
13.9 Genentech
13.10 Lupin Pharmaceuticals Inc
13.11 Sandoz International GmbH
13.12 AbbVie Inc.
13.13 Codexis
13.14 Merck & Co.
13.15 American Gene Technologies
13.16 Johnson & Johnson Services Inc
13.17 F. Hoffmann-La Roche Limited
13.18 Ultragenyx Pharmaceutical
13.19 Abbott Laboratories
13.20 BioMarin
List of Tables
1 Global Turner Syndrome Market Outlook, By Region (2021-2030) ($MN)
2 Global Turner Syndrome Market Outlook, By Type (2021-2030) ($MN)
3 Global Turner Syndrome Market Outlook, By Mosaic Turner Syndrome (2021-2030) ($MN)
4 Global Turner Syndrome Market Outlook, By Classical Turner Syndrome (2021-2030) ($MN)
5 Global Turner Syndrome Market Outlook, By Drug Type (2021-2030) ($MN)
6 Global Turner Syndrome Market Outlook, By Oxandrolone (2021-2030) ($MN)
7 Global Turner Syndrome Market Outlook, By Oxandrin (2021-2030) ($MN)
8 Global Turner Syndrome Market Outlook, By Norditropin (2021-2030) ($MN)
9 Global Turner Syndrome Market Outlook, By Somatropin (2021-2030) ($MN)
10 Global Turner Syndrome Market Outlook, By Genotropin (2021-2030) ($MN)
11 Global Turner Syndrome Market Outlook, By Humatrope (2021-2030) ($MN)
12 Global Turner Syndrome Market Outlook, By Zomacton (2021-2030) ($MN)
13 Global Turner Syndrome Market Outlook, By Nutropin (2021-2030) ($MN)
14 Global Turner Syndrome Market Outlook, By Therapy Type (2021-2030) ($MN)
15 Global Turner Syndrome Market Outlook, By Progesterone Replacement Therapy (2021-2030) ($MN)
16 Global Turner Syndrome Market Outlook, By Oestrogen Replacement Therapy (2021-2030) ($MN)
17 Global Turner Syndrome Market Outlook, By Growth Hormone Therapy (2021-2030) ($MN)
18 Global Turner Syndrome Market Outlook, By Psychological Therapy (2021-2030) ($MN)
19 Global Turner Syndrome Market Outlook, By Other Therapy Types (2021-2030) ($MN)
20 Global Turner Syndrome Market Outlook, By Diagnosis (2021-2030) ($MN)
21 Global Turner Syndrome Market Outlook, By Physical Examination (2021-2030) ($MN)
22 Global Turner Syndrome Market Outlook, By Karyotyping (2021-2030) ($MN)
23 Global Turner Syndrome Market Outlook, By Prenatal Testing (2021-2030) ($MN)
24 Global Turner Syndrome Market Outlook, By Amniocentesis (2021-2030) ($MN)
25 Global Turner Syndrome Market Outlook, By Ultrasound Test (2021-2030) ($MN)
26 Global Turner Syndrome Market Outlook, By Chorionic Villus Sampling (2021-2030) ($MN)
27 Global Turner Syndrome Market Outlook, By Other Diagnosis (2021-2030) ($MN)
28 Global Turner Syndrome Market Outlook, By Route Of Administration (2021-2030) ($MN)
29 Global Turner Syndrome Market Outlook, By Oral (2021-2030) ($MN)
30 Global Turner Syndrome Market Outlook, By Sub-cutaneous (2021-2030) ($MN)
31 Global Turner Syndrome Market Outlook, By Intravenous (2021-2030) ($MN)
32 Global Turner Syndrome Market Outlook, By Intramuscular (2021-2030) ($MN)
33 Global Turner Syndrome Market Outlook, By Other Route Of Administrations (2021-2030) ($MN)
34 Global Turner Syndrome Market Outlook, By End User (2021-2030) ($MN)
35 Global Turner Syndrome Market Outlook, By Research Organizations (2021-2030) ($MN)
36 Global Turner Syndrome Market Outlook, By Hospitals & Clinics (2021-2030) ($MN)
37 Global Turner Syndrome Market Outlook, By Academic Institutes (2021-2030) ($MN)
38 Global Turner Syndrome Market Outlook, By Other End Users (2021-2030) ($MN)
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.
List of Figures
RESEARCH METHODOLOGY
We at ‘Stratistics’ opt for an extensive research approach which involves data mining, data validation, and data analysis. The various research sources include in-house repository, secondary research, competitor’s sources, social media research, client internal data, and primary research.
Our team of analysts prefers the most reliable and authenticated data sources in order to perform the comprehensive literature search. With access to most of the authenticated data bases our team highly considers the best mix of information through various sources to obtain extensive and accurate analysis.
Each report takes an average time of a month and a team of 4 industry analysts. The time may vary depending on the scope and data availability of the desired market report. The various parameters used in the market assessment are standardized in order to enhance the data accuracy.
Data Mining
The data is collected from several authenticated, reliable, paid and unpaid sources and is filtered depending on the scope & objective of the research. Our reports repository acts as an added advantage in this procedure. Data gathering from the raw material suppliers, distributors and the manufacturers is performed on a regular basis, this helps in the comprehensive understanding of the products value chain. Apart from the above mentioned sources the data is also collected from the industry consultants to ensure the objective of the study is in the right direction.
Market trends such as technological advancements, regulatory affairs, market dynamics (Drivers, Restraints, Opportunities and Challenges) are obtained from scientific journals, market related national & international associations and organizations.
Data Analysis
From the data that is collected depending on the scope & objective of the research the data is subjected for the analysis. The critical steps that we follow for the data analysis include:
- Product Lifecycle Analysis
- Competitor analysis
- Risk analysis
- Porters Analysis
- PESTEL Analysis
- SWOT Analysis
The data engineering is performed by the core industry experts considering both the Marketing Mix Modeling and the Demand Forecasting. The marketing mix modeling makes use of multiple-regression techniques to predict the optimal mix of marketing variables. Regression factor is based on a number of variables and how they relate to an outcome such as sales or profits.
Data Validation
The data validation is performed by the exhaustive primary research from the expert interviews. This includes telephonic interviews, focus groups, face to face interviews, and questionnaires to validate our research from all aspects. The industry experts we approach come from the leading firms, involved in the supply chain ranging from the suppliers, distributors to the manufacturers and consumers so as to ensure an unbiased analysis.
We are in touch with more than 15,000 industry experts with the right mix of consultants, CEO's, presidents, vice presidents, managers, experts from both supply side and demand side, executives and so on.
The data validation involves the primary research from the industry experts belonging to:
- Leading Companies
- Suppliers & Distributors
- Manufacturers
- Consumers
- Industry/Strategic Consultants
Apart from the data validation the primary research also helps in performing the fill gap research, i.e. providing solutions for the unmet needs of the research which helps in enhancing the reports quality.
For more details about research methodology, kindly write to us at info@strategymrc.com
Frequently Asked Questions
In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.
Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.
All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
We have 3 different licensing options available in electronic format.
- Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
- 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
- Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.
All our reports are typically be emailed to you as an attachment.
To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.
We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.
Request Customization
We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.
WHY CHOOSE US ?
Assured Quality
Best in class reports with high standard of research integrity
24X7 Research Support
Continuous support to ensure the best customer experience.
Free Customization
Adding more values to your product of interest.
Safe & Secure Access
Providing a secured environment for all online transactions.
Trusted by 600+ Brands
Serving the most reputed brands across the world.
